Sort
50,496 grants matching “lung cancer”
A no-gold-standard framework to objectively evaluate quantitative imaging methods with patient data
$489,138Abhinav K Jha · Washington University · R01 · FY2022 · EB
A novel molecular diagnostic approach to classify lung cancers and predict respon
$489,074Bruce J Mayer · University Of Connecticut Sch Of Med/Dnt · RC1 · FY2010 · CA
Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study
$489,073Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2021 · CA
Development of Parametric Response Mapping Software for Clinical Cancer Response Assessment
$489,069Lauren Keith · Imbio, Llc · R44 · FY2018 · CA
Improving pathologic nodal staging of resected lung cancer
$489,062Raymond U Osarogiagbon · Baptist Memorial Hospital - Tipton · R01 · FY2020 · CA
Lead identification and pre-clinical studies on allosteric inhibitors of coagulation factor XIa
$489,038Umesh Ramanlal Desai · Virginia Commonwealth University · R33 · FY2024 · HL
Methods for Epidemiology Studies
$489,013Paul Albert · Division Of Cancer Epidemiology And Genetics · ZIA · FY2024 · CA
To study the EMT contributions in tumor metastasis and chemoresistance by using lineage tracing models
$489,007Dingcheng Gao · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA
Optimization of Ex Vivo- and In Vivo- Generated Platelets
$489,000Mortimer Poncz · Children'S Hosp Of Philadelphia · R01 · FY2016 · HL
OCCUPATIONAL AND ENVIRONMENTAL HEALTH
$489,000Harvard University (Sch Of Public Hlth) · P30 · FY2003 · ES
Optimization of Ex Vivo- and In Vivo- Generated Platelets
$489,000Mortimer Poncz · Children'S Hosp Of Philadelphia · R01 · FY2017 · HL
QUANTITATIVE DUAL-ENERGY CT IMAGING FOR CANCER IMAGING AND RADIATION THERAPY APPLICATIONS
$488,888Joseph A O'Sullivan · Washington University · R01 · FY2017 · CA
Lung Screening: Efficacy versus Effectiveness
$488,886Ilana F Gareen · Brown University · R01 · FY2023 · CA
Using 18F-EF5 PET to measure hypoxia modulation by Nelfinavir in larynx cancer
$488,805Amit Maity · University Of Pennsylvania · R01 · FY2015 · CA
Using 18F-EF5 PET to measure hypoxia modulation by Nelfinavir in larynx cancer
$488,805Amit Maity · University Of Pennsylvania · R01 · FY2016 · CA
Epigenetic mechanisms of transcriptional activation of a novel oncogenic ALK variant in cancer
$488,718Ping Chi · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
avb6-directed molecular imaging and therapy
$488,662Julie L Sutcliffe · University Of California At Davis · R01 · FY2018 · CA
avb6-directed molecular imaging and therapy
$488,662Julie L Sutcliffe · University Of California At Davis · R01 · FY2017 · CA
Project I: Systems analysis of tumor-stroma interactions in brain metastasis
$488,632Joan Massague · Sloan-Kettering Inst Can Research · U54 · FY2024 · CA
Canine models for characterization, diagnosis, and treatment of human cancers using comparative canine-human transcriptomics
$488,591Gregory Tawa · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR
Optimization and Validation of an indicator cell assay for blood-based diagnosis of lung cancer
$488,587Jennifer Joy Smith · Precyte, Inc. · R44 · FY2021 · CA
The Impact of Oxidative Stress on HIV-induced Lung Disease
$488,507Julio Alberto Ramirez · University Of Louisville · U01 · FY2016 · HL
The Impact of Oxidative Stress on HIV-induced Lung Disease
$488,507Julio Alberto Ramirez · University Of Louisville · U01 · FY2017 · HL
Truncated O-glycan-dependent mechanisms inducing metastatic dissemination in pancreatic cancer
$488,488Moorthy P. Ponnusamy · University Of Nebraska Medical Center · R01 · FY2024 · CA
Mechanisms of adaptation and resistance to emerging therapies for lung cancer
$488,477Piro Lito · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA